
Sign up to save your podcasts
Or


Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
By The JAMA Network4.9
1212 ratings
Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial

137 Listeners

317 Listeners

697 Listeners

498 Listeners

35 Listeners

105 Listeners

298 Listeners

3,348 Listeners

38 Listeners

12 Listeners

16 Listeners

19 Listeners

7 Listeners

1,148 Listeners

30 Listeners

194 Listeners

92 Listeners

515 Listeners

367 Listeners

426 Listeners

18 Listeners

370 Listeners

60 Listeners